Skip to main content

MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in NVAX — Novavax Inc

CIK 912938 Boston, MA

Position in NVAX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,518,089
+$178,629 QoQ
Shares Held
161,156
-2.1% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 263 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 83% Shared 17% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. NVAX ranks #32 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,518,089 161,156
2026-03-31 $1,339,460 164,553
2025-12-31 $1,337,991 199,106
2025-09-30 $833,715 96,161
2025-06-30 $565,973 89,837
2025-03-31 $568,746 88,728
2024-12-31 $729,613 90,748
2024-09-30 $1,180,361 93,457
2024-06-30 $952,386 75,228
2023-03-31 $125,571 18,120
2022-12-31 $191,567 18,635
2022-09-30 $331,968 18,240
2022-06-30 $946,620 18,406
2022-03-31 $648,120 8,800
2021-09-30 $981,405 4,734
2021-06-30 $1,983,187 9,341
2021-03-31 $3,159,870 17,428
2020-12-31 $2,178,236 19,534
2020-09-30 $2,137,962 19,732